相关实验视频

Updated: Jun 17, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

与代谢重编程相关的基因特征与BLCA的预后和扩散有关

Yaoxin Wu¹, Yi Luo², Tinghao Li³

¹Health Management Center, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Discover oncology

|August 8, 2024

概括

研究人员确定了三种基因特征 (AK3,GALK1,NUP205) 来预测膀癌 (BLCA) 的预后. 抑制NUP205通过AMPK途径失活减少了癌细胞糖解和扩散,这表明NUP205是治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
代谢途径代谢途径

背景情况:

膀癌 (BLCA) 是一种常见的尿癌,由于预测生物标志物有限,预后不佳.
代谢重编程与BLCA的恶性进展密切相关.
确定可靠的生物标志物对于改善BLCA患者的治疗结果至关重要.

研究的目的:

建立一种与糖解相关的基因特征,用于预测BLCA患者的预后.
探索NUP205在BLCA进展中的作用和机制.
为了确定BLCA治疗的潜在治疗点.

主要方法:

利用了349名BLCA患者的转录基因组测序数据 (癌症基因组图谱).
开发了基于AK3,GALK1和NUP205表达的三基因特征.
构建了一个整合临床变量和风险评分的诺莫图.
研究了NUP205在BLCA细胞糖解和增殖中的作用,包括对AMPK信号通路的影响.

主要成果:

一个三基因签名 (AK3,GALK1,NUP205) 有效地预测了BLCA的预后,特别是在晚期.
签名显示了临床预测能力,当集成到一个nomogram.
抑制NUP205降低了BLCA细胞糖解和增殖.
抑制NUP205主要通过AMPK信号通路的失活起作用.

结论:

开发的三基因特征是预测BLCA预后的宝贵工具.
NUP205被确定为一种潜在的治疗点,用于抑制BLCA中的糖解和增殖.
准NUP205可能为膀癌治疗提供一种新的策略.

关键词:

膀癌是一种癌症.代谢重编程是一种代谢重编程.在 NUP2055 中使用.预测预测预测预测核武器的扩散

更多相关视频

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Cell-Free DNA Integrity Analysis in Urine Samples

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...